Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banwell, B. L.
Right arrow Articles by Shemie, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banwell, B. L.
Right arrow Articles by Shemie, S. D.
Related Collections
Right arrow Muscle disease
Right arrow All Pediatric
Right arrow Critical care
NEUROLOGY 2003;61:1779-1782
© 2003 American Academy of Neurology

Muscle weakness in critically ill children

B. L. Banwell, MD, R. J. Mildner, MD, A. C. Hassall, MSc, L. E. Becker, MD, J. Vajsar, MD and S. D. Shemie, MD

From the Departments of Pediatrics (Neurology [Drs. Banwell and Vajsar], Critical Care Medicine [Drs. Mildner and Shemie, A.C. Hassal], and Neuropathology [Dr. Becker]), Hospital for Sick Children, Toronto, Ontario, Canada.

Address correspondence to Dr. B.L. Banwell, Department of Pediatrics (Neurology), Hospital for Sick Children, 555 University Ave., Toronto, Ontario, Canada M5G 1X8; e-mail: brenda.banwell{at}sickkids.ca

Objective: To establish the incidence of muscle weakness in critically ill children.

Methods: Neuromuscular examinations were performed in 830 children without identified antecedent or acute neuromuscular disease (age 3 months to 17 years 11 months) admitted for >24 hours to a pediatric intensive care unit (ICU) over a 1-year period.

Results: Fourteen of 830 (1.7%) patients had generalized weakness. Four failed repeated attempts to extubate. Multiple organ dysfunction occurred in 11 patients and sepsis in 9. Most children received corticosteroids, neuromuscular blocking agents, or aminoglycoside antibiotics. Eight of the 14 children were solid organ or bone marrow transplant recipients. Muscle biopsy showed evidence of acute quadriplegic myopathy in all three patients in whom biopsy was performed. Three patients died. In survivors, significant weakness persisted for 3 to 12 months following ICU discharge.

Conclusions: Muscle weakness is an infrequent but significant feature of critical illness in children. Transplant recipients seem to be at particular risk.

Received November 26, 2002. Accepted in final form September 5, 2003.

Drs. Banwell and Mildner contributed equally to this work.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Fredriksson, F. Hammarqvist, K. Strigard, K. Hultenby, O. Ljungqvist, J. Wernerman, and O. Rooyackers
Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1044 - E1050.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.